Abstract | OBJECTIVES: MATERIALS AND METHODS: In this retrospective study, conducted between October 1988 and March 2015, four hundred seventy-three liver transplants were performed at our institution. Of these, 231 were pediatric and 242 were adult. Among these patients, liver transplant was performed in 58 patients (12.3%) for treatment of hepatocellular carcinoma. RESULTS: CONCLUSIONS: As expected, outcomes were significantly better in the Milan criteria group. Although the overall- and disease-free survival rates were promising in such a group of patients who had no better chance, it could be asserted that liver transplant is a safe and effective treatment option with promising results, even if the tumor expanse is beyond the Milan criteria.
|
Authors | Gokhan Moray, Mahir Kirnap, Aydincan Akdur, Ebru Soy, Tugan Tezcaner, Fatih Boyvat, Handan Ozdemir, Mehmet Haberal |
Journal | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
(Exp Clin Transplant)
Vol. 13 Suppl 3
Pg. 30-2
(Nov 2015)
ISSN: 2146-8427 [Electronic] Turkey |
PMID | 26640906
(Publication Type: Journal Article)
|
Topics |
- Carcinoma, Hepatocellular
(diagnosis, mortality, surgery)
- Disease Progression
- Disease-Free Survival
- Humans
- Liver Neoplasms
(diagnosis, mortality, surgery)
- Liver Transplantation
(adverse effects, mortality)
- Neoplasm Recurrence, Local
- Retrospective Studies
- Risk Factors
- Survival Analysis
- Time Factors
- Treatment Outcome
|